Atlas Trials

Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe

Clinical trial NCT00127296 · COMPLETED

Trial details

NCT number
NCT00127296
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2Delivery Systems
Start date
2005-07-01
Primary completion
2005-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.